The pathophysiology of elevated vitamin b12 in clinical practice

QJM: An International Journal of Medicine

Volumn 106, Issue 6, 2013, Pages 505-515

  Andres E ^a   Serraj, K ^a   Zhu, J ^b   Vermorken, A J M ^b  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; TRANSCOBALAMIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; CLINICAL PRACTICE; CYANOCOBALAMIN DEFICIENCY; DISEASE ASSOCIATION; DISEASE MARKER; HEMATOLOGIC DISEASE; HUMAN; HYPERCOBALAMINEMIA; LIVER DISEASE; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; VITAMIN BLOOD LEVEL; VITAMIN INTAKE; VITAMIN METABOLISM;

EID: 84878631898     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hct051     Document Type: Review

References (90)

1. Chiche L, Jean R, Romain F, Roux F, Thomas G, Canavese S, et al. Implications cliniques de la découverte d'une hypervitaminémie B12 en médecine interne. Rev Med Interne 2008; 29:187-94.
2. Arendt JFB, Nexo E. Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. PLoS ONE 2012; 9:e45979.
3. Deneuville T, Mario N, Tiev KP, Tolédano C, Josselin-1e11 Mahr L, Gain M, et al. Concentrationplasmatique élevée de la vitamine B12: un indicateur des maladies hépatiques ou tumorales. Rev Med Interne 2009; 30(Suppl. 2):S73.
4. Carmel R, Vasireddy H, Aurangzeb I, George K. High serum cobalamin levels in the clinical setting-clinical associations and holo-transcobalamin changes. Clin Lab Haematol 2001; 23:365-71.
5. Chiche L, Mancini J, Arlet JB, investigateurs. de l'étude BDOSE. Hypervitaminémies B12 en médecine interne: résultats de l'étude BDOSE. Rev Med Interne 2009; 30(Suppl. 4):S377.
6. Whipple GH, Hooper CW, Robscheit FS. Blood regeneration following anemia. IV. Influence of meat, liver, and various extractives, alone or combined with standard diets. Am J Physiol 1920; 53:236-62.
7. Minot GR, Murphy WP. Treatment of pernicious anemia by special diet. JAMA 1926; 87:470-6.
8. Minot GR, Murphy WP, Stetson RP. Response of reticulocytes to liver therapy: particularly in pernicious anemia. Am J Med Sci 1928; 175:581-99.
9. Castle WB. Observations on etiologic relationship of achylia gastrica to pernicious anemia. I. Effect of administration to patients with pernicious anemia of contents of normal human stomach recovered after ingestion of beef muscle. Am J Med Sci 1929; 178:748-64.
10. Castle WB, Townsend WC, Heath CW. Observations on etiologic relationship of achylia gastrica to pernicious anemia. II. Effect of administration to patients with pernicious anemia of beef muscle after incubation with normal human gastric juice. Am J Med Sci 1929; 178:764-77.
11. Castle WB, Townsend WC, Heath CW. Observations on etiologic relationship of achylia gastrica to pernicious anemia. III. Nature of reaction between normal human gastric juice and beef muscle leading to clinical improvement and increased blood formation similar to effect of liver feeding. Am J Med Sci 1930; 180:305-35.
12. Castle WB, Heath CW, Strauss MB, Heinle RW. Observations on etiologic relationship of achylia gastrica to pernicious anemia.VI. Site of interaction of food (extrinsic) and gastric (intrinsic) factors: failure of in vitro incubation to produce thermostable hematopoietic principle. Am J Med Sci 1937; 294:618-25.
13. Smith EL. Purification of anti-pernicious anemia factors from liver. Nature 1948; 161:638-9.
14. Rickes EL, Brink NG, Koniuszy FR, Wood TR, Folkers K. Crystalline vitamin B12. Science 1948; 107:396-7.
15. Gärsbeck R. Studies on the vitamin B12-binding principle and other biocolloids of human gastric juice. Acta Med Scand 1956; 314(Suppl.):1-87.
16. Gärsbeck R. Fractionation of human gastric juice and saliva employing starch electrophoresis. Gastroenterologia 1955; 84:99-102.
17. Okuda K. Discovery of vitamin B12 in the liver and its absorption factor in the stomach: a historical review. J Gastroenterol Hepatol 1999; 14:301-8.
18. Glass GBJ. Gastric intrinsic factor and its function in the metabolism of vitamin B12. Physiol Rev 1963; 43:529-849.
19. Kozyraki R, Fyfe J, Kristiansen M, Gerdes C, Jacobsen C, Cui S, et al. The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat Med 1999; 5:656-61.
20. Tanner SM, Aminoff M, Wright FA, Liyanarachchi S, Kuronen M, Saarinen A, et al. Amnionless, essential for mouse gastrulation, is mutated in recessive hereditary megaloblastic anemia. Nat Genet 2003; 33:426-9.
21. Fyfe FC, Madsen M, Hojrup P, Christensen EI, Tanner SM, de la Chapelle A, et al. The functional cobalamin (vitamin B12)-intrinsic factor receptor is a novel complex of cubilin and amnionless. Blood 2004; 103:1573-9.
22. Gräsbeck R. Imerslund-Gräsbeck syndrome (selective vitamin B(12) malabsorption with proteinuria). Orphanet J Rare Dis 2006; 1:17.
23. Andrès E, Fothergill H, Mecili M. Efficacy of oral cobalamin (vitamin B12) therapy. Expert Opin Pharmacother 2010; 11:249-56.
24. Andrès E, Henoun Loukili N, Noel E, Maloisel F, Vinzio S, Kaltenbach G, et al. Oral cobalamin (daily dose of 1000 mg) therapy for the treatment of patients with pernicious anemia. An open label study of 10 patients. Curr Ther Res 2005; 66:13-22.
25. Solomon LR. Oral pharmacologic doses of cobalamin may not be as effective as parenteral cobalamin therapy in reversing hyperhomocystinemia and methylmalonic acidemia in apparently normal subjects. Clin Lab Haematol 2006; 28:275-8.
26. Herbert V. Recommended dietary intakes (RDI) of vitamin B-12 in humans. Am J Clin Nutr 1987; 45:671-8.
27. Fenech MF, Dresoti IE, Rinaldi JR. Folate, vitamin B12, homocysteine status and chromosome damage rate in lymphocytes of older men. Carcinogenesis 1997; 18:1329-36.
28. Fenech M, Aitken C, Rinaldi J. Folate, vitamin B12, homocysteine status and DNA damage in young Australian adults. Carcinogenesis 1998; 19:1163-71.
29. Kapiszewska M, Kalemba M, Wojciech U, Milewicz T. Uracil misincorporation into DNA of leukocytes of young women with positive folate balance depends on plasma vitamin B12 concentrations and methylenetetrahydrofolate reductase polymorphisms. A pilot study. J Nutr Biochem 2005; 16:467-78.
30. Solomon LR. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 2007; 21:113-30.
31. Andrès E, Vidal-Alaball J, Federici L, Loukili NH, Zimmer J, Kaltenbach G. Clinical aspects of cobalamin deficiency in elderly patients. Epidemiology, causes, clinical manifestations, and treatment with special focus on oral cobalamin therapy. Eur J Intern Med 2007; 18:456-62.
32. Andrès E, Affenberger S, Vinzio S, Noel E, Kaltenbach G, Schlienger JL. Carences en vitamine B12 chez l'adulte: étiologies, manifestations cliniques et traitement. Rev Med Interne 2005; 26:938-46.
33. Serraj K, Mecili M, Andres E. Signes et symptômes de la carence en vitamine B12: revue critique de la littérature. Méd Thé r 2010; 16:13-20.
34. Andrès E, Loukili NH, Noel E, Kaltenbach G, Ben Abdelgheni M, Perrin AE, et al. Vitamin B12 (cobalamin) deficiency in elderly patients. CAMJ 2004; 171:251-60.
35. Russel RM. Vitamin requirements in old age. Age Nutr 1992; 3:20-3.
36. Federici L, Henoun Loukili N, Zimmer J, Affenberger S, Maloisel F, Andrès E. Manifestations hématologiques de la carence en vitamine B12: données personnelles et revue de la littérature. Rev Med Interne 2007; 28:225-31.
37. Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clin Biochem 2003; 36:585-90.
38. Lindemans J, Kroes ACM, van Geel J, Van Kapel J, Schoester M, Abels J. Uptake of transcobalamin II-bound cobalamin by HL-60 cells: effects of differentiation induction. J Exp Cell Res 1989; 184:449-60.
39. Herzlich B, Herbert V. Depletion of serum holotranscobalamin II. An early sign of negative vitamin B12 balance. Lab Invest 1988; 58:332-7.
40. Herrmann W, Schorr H, Obeid R, Geisel J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr 2003; 78:131-6.
41. Grasbeck R. Biochemistry and clinical chemistry of vitamin B12 transport and the related diseases. J Clin Biochem 1984; 17:99-107.
42. Nicolas JP, Gueant JL, Frémont S. Cobalamin binding glycoproteins. In: Bhatt HR, James VHT, Besser GM, Bottazzo GF, Keen H, eds, Advances in Thomas Addison's Diseases. Bristol: Journal of Endocrinology Ltd., 1994:253-67.
43. Gräsbeck R. Intrinsic factor and the other vitamin B12 transport proteins. Prog Hematol 1969; 6:233-60.
44. Burger RL, Mehlman CS, Allen RH. Human plasma R-type vitamin B12-binding proteins. I. Isolation and characterization of transcobalamin I, transcobalamin III and the normal granulocyte vitamin B12-binding protein. J Biol Chem 1975; 250:7700-6.
45. Zittoun J. Cobalamins: an update of fundamental and clinical data. Hématologie 1996; 2:119-29.
46. Li N, Seetharam S, Lindemans J, Alpers DH, Arwert F, Seetharam B. Isolation and sequence analysis of variant forms of human transcobalamin II. Biochim Biophys Acta 1993; 1172:21-30.
47. Herbert V. Etiology of vitamin B12 (cobalamin) deficiency and staging of B12 status. In: Bhatt HR, James VHT, Besser GM, Bottazzo GF, Keen H, eds, Advances in Thomas Addison's Diseases. Bristol: Journal of Endocrinology Ltd, 1994:139-48.
48. Vogeser M, Lorenzl S. Comparison of automated assays for the determination of vitamin B12 in serum. Clin Biochem 2007; 40:1342-5.
49. Karmi O, Zayed A, Baraghethi S, Qadi M, Ghanem R. Measurement of vitamin B12 concentration: a review of available methods. IIOAB J 2011; 2:23-32.
50. Carmel R. Current concepts in cobalamin deficiency. Annu Rev Med 2000; 51:357-75.
51. Solomon LR. Cobalamin-responsive disorders in the ambulatory care setting: unreliability of cobalamin, methylmalonic acid, and homocysteine testing. Blood 2005; 105:978-85.
52. Rogers EJ, Chen S, Chan A. Folate deficiency and plasma homocysteine during increased oxidative stress. N Engl J Med 2007; 357:421-2.
53. Solomon LR. Diabetes as a cause of clinically significant functional cobalamin deficiency. Diabetes Care 2011; 34:1077-80.
54. Solomon LR. More on failures of cobalamin assays in pernicious anemia. N Engl J Med 2012; 367:1570.
55. Andrès E, Serraj K, Mecili M, Ciobanu E, Vogel T, Weitten T. Mise au point sur la vitamine B12 administrée par voie orale. Ann Endocrinol 2009; 70:453-61.
56. Solomon LR. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev 2007; 21:113-30.
57. Kanazawa S, Herbert V. Total corrinoid, cobalamin and cobalamin analogue levels may be normal in serum despite cobalamin in liver depletion in patients with alcoholism. Lab Invest 1985; 53:108-10.
58. Baker H, Leevy CB, DeAngelis B, Frank O, Baker ER. Cobalamin and holotranscobalamin changes in plasma and liver tissue in alcoholics with liver disease. J Am Coll Nutr 1998; 17:235-8.
59. Hagelskjaer L, Rasmussen K. Methylmalonic acid concentration in serum not affected in hepatic disease. Clin Chem 1992; 38:493-5.
60. Lambert D, Benhayoun S, Adjalla C, Gélot MM, Renkes P, Gérard P, et al. Alcoholic cirrhosis and cobalamin metabolism. Digestion 1997; 58:64-71.
61. Carmel R, Eisenberg L. Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer 1977; 40:1348-53.
62. Gauchan D, Joshi N, Gill AS, Patel V, De Bari VA, Guron G, et al. Does an elevated serum vitamin B12 level mask actual vitamin B12 deficiency in myeloproliferative disorders? Clin Lymph Myel Leukemia 2012; 12:269-73.
63. Carmel R, Tatsis B, Baril L. Circulating antibody to transcobalamin II causing retention of vitamin B12 in the blood. Blood 1977; 49:987-1000.
64. Bowen RA, Drake SK, Vanjani R, Huey ED, Grafman J, Horne MK 3rd. Markedly increased vitamin B12 concentrations attributable to IgG-IgM-vitamin B12 immune complexes. Clin Chem 2006; 52:2107-14.
65. Schwartz M, Bastrup-Madsen P. A new vitamin B12 binding protein in serum causing excessively high serum vitamin B12 values. Scand J Haematol 1968; 5:35-40.
66. Rain JD. Intérêt en hématologie du dosage des cobalamines. Immunoanal Biol Spec 1992; 32:17-24.
67. Serraj K, Vogel T, Federici L, Ciobanu E, Mecili M, Kaltenbach G, et al. Le syndrome de Non-Dissociation de la Vitamine B12 de ses Protéines Porteuses ou de Mal Digestion des cobalamines alimentaires. Presse Med 2009; 38:55-62.
68. Carmel R. Extreme elevation of serum transcobalamin I in patients with metastatic cancer. N Engl J Med 1975; 292:282-4.
69. Fremont S, Chamigneulle B, Gerard P, Felden P, Lambert D, Gueant JL, et al. Blood transcobalamin levels in malignant hepatoma. Tumor Biol 1991; 12:353-9.
70. Gimsing P, Hippe E. Increased concentration of transcobalamin I in a patient with metastatic carcinoma of the breast. Scand J Haematol 1978; 21:243-9.
71. Kane SP, Murray-Lyon IM, Paradinas FJ, Johnson PJ, Williams R, Orr HA, et al. Vitamin B12 binding protein as a tumour marker for hepatocellular carcinoma. Gut 1978; 19:1105-9.
72. Wheeler K, Pritchard J, Luck W, Rossiter M. Transcobalamin I as a marker for fibrolamellar hepatoma. Med Ped Oncol 1986; 14:227-9.
73. Salles N, Herrmann F, Sakbani K, Rapin CH, Sieber C. High vitamin B12 level: a strong predictor of mortality in elderly inpatients. J Am Geriatr Soc 2005; 53:917-8.
74. Gimsing P. Cobalamin metabolism in chronic myelogenous leukemia. Dan Med Bull 1998; 45:459-79.
75. Arnalich F, Zamorano AF, Martinez-Hernandez P, Pena JM, Barbado FJ, Vazquez JJ. Additional predictive value of serum unsaturated vitamin B12 proteins in multiple myeloma. J Med 1990; 21:277-86.
76. Vlasveld LT. Low cobalamin levels in multiple myeloma: a retrospective study. Neth J Med 2003; 61:249-52.
77. Gimsing P. The cobalamin forms and analogues in plasma and myeloid cells during the course of chronic myelogenous leukemia related to the clinical condition. Br J Haematol 1995; 89:812-9.
78. Rachmilewitz B, Manny N, Rachmilewitz M. The transcobalamins in polycythemia vera. Scand J Haematol 1977; 19:453-62.
79. Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoun R. Cobalamin vitamin B12 (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood 1984; 63:779-83.
80. Rachmilewitz D, Rachmilewitz EA, Polliack A, Herchko CA. Acute promyelocytic leukemia. A report of five cases with a comment on the diagnostic significance of serum vitamin B12 determination. Br J Haematol 1972; 22:87-92.
81. Hagelskjaer L, Rasmussen K. Methylmalonic acid concentration in serum not affected in hepatic disease. Clin Chem 1992; 38:493-5.
82. Fragasso A, Mannarella C, Ciancio A, Sacco A. Functional vitamin B12 deficiency in alcoholics: an intriguing finding in a retrospective study of megaloblastic anemic patients. Eur J Intern Med 2010; 21:97-100.
83. Hofer LJ, Elian KM. Parenteral vitamin B12 therapy of hyperhomocysteinemia in end-stage renal disease. Med Clin Exp 2004; 27:10-3.
84. Carmel R, Tatsis B, Baril L. Circulating antibody to transcobalamin II causing retention of vitamin B12 in the blood. Blood 1977; 49:987-1000.
85. Reynolds EH, Bottiglieri T, Laundry M, Stern J, Payan J, Linnell J, et al. Subacute combined degeneration with high serum vitamin B12 level and abnormal vitamin B12 binding protein. Arch Neurol 1993; 50:739-42.
86. Molad Y, Rachmilewitz B, Sidi Y, Pinkhas J, Weinberger A. Serum transcobalamin and transcobalamin levels in systemic lupus erythematosus. Am J Med 1989; 88:141-4.
87. Grindulis KA, Calverley M, Cox C. Rheumatoid arthritis: is serum vitamin B12 high in active disease. J Rheumatol 1984; 11:211-2.
88. Kalyoncu U, Buyukasik Y, Akdogan A, Karadag O, Bilgen SA, Kiraz S, et al. Increased serum vitamin B12 levels are associated with adult-onset Still's disease with reactive macrophage activation syndrome. Joint Bone Spine 2010; 77:131-4.
89. Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoun R. Cobalamin and B12 binding proteins in hypereosinophilic syndromes and hypereosinophilia. Blood 1984; 63:779-83.
90. Serraj K, Mecili M, Housni I, Andrès E. L'hypervitaminémie B12: physiopathologie et intérê t en pratique clinique. Press Med 2011; 40:1120-7.